文献速递认知障碍与痴呆

遗传性额颞叶痴呆症状前携带者的纵向脑萎缩率

Longitudinal Brain Atrophy Rates in Presymptomatic Carriers of Genetic Frontotemporal Dementia.
PubMed 文献 · Neurology · 2022-12-12

本研究为前瞻性队列研究,纳入34例GRN、8例MAPT和14例C9orf72致病性变异携带者,使用Quantib® ND软件纵向分析脑容量,并与基于4951名非痴呆个体的参考百分位曲线比较。结果显示症状前阶段已存在纵向脑萎缩,且不同基因组的萎缩脑区和加速年龄不同,提示常模体积测量软件有助于疾病追踪和分期。

要点

  • GRN携带者所有脑区萎缩快于参考曲线,但45至70岁相对体积仍介于第5至75百分位。
  • MAPT携带者45岁时额叶体积已处于第5百分位,50至60岁进一步下降。
  • C9orf72携带者45岁时额叶、颞叶、顶叶和小脑体积已低于第5百分位,但至60岁萎缩轻微。

核心结论

  • 研究提供证据表明遗传性额颞叶痴呆症状前阶段已存在纵向脑萎缩,且萎缩加速的脑区和年龄因基因分组而异。

研究设计与样本

  • 前瞻性队列研究,纳入34例GRN、8例MAPT和14例C9orf72致病性变异携带者,平均年龄52.1岁(标准差7.2),66%为女性。
  • 平均随访64±33个月(中位数52,范围13-108),纵向进行脑部T1加权磁共振成像。
  • 图像用Quantib® ND自动分析,测量脑叶、小脑和海马的体积(脑脊液及灰白质总和),并与基于4951名非痴呆个体的参考百分位曲线比较。

主要发现

  • GRN携带者所有脑区萎缩快于参考百分位曲线,但45至70岁相对体积仍介于第5至75百分位。
  • MAPT携带者45岁时额叶体积已处于第5百分位,50至60岁进一步下降;颞叶体积45岁时处于第50百分位,但随时间下降最快。
  • C9orf72携带者45岁时额叶、颞叶、顶叶和小脑体积已低于参考百分位曲线的第5百分位,但至60岁萎缩轻微。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: It is important to identify at what age brain atrophy rates in genetic frontotemporal dementia (FTD) start to accelerate and deviate from normal aging effects to find the optimal starting point for treatment. We investigated longitudinal brain atrophy rates in the presymptomatic stage of genetic FTD using normative brain volumetry software. METHODS: Presymptomatic GRN, MAPT, and C9orf72 pathogenic variant carriers underwent longitudinal volumetric T1-weighted magnetic resonance imaging of the brain as part of a prospective cohort study. Images were automatically analyzed with Quantib® ND, which consisted of volume measurements (CSF and sum of gray and white matter) of lobes, cerebellum, and hippocampus. All volumes were compared with reference centile curves based on a large population-derived sample of nondemented individuals (n = 4,951). Mixed-effects models were fitted to analyze atrophy rates of the different gene groups as a function of age. RESULTS: Thirty-four GRN, 8 MAPT, and 14 C9orf72 pathogenic variant carriers were included (mean age = 52.1, standard deviation = 7.2; 66% female). The mean follow-up duration of the study was 64 ± 33 months (median = 52; range 13-108). GRN pathogenic variant carriers showed a faster decline than the reference centile curves for all brain areas, though relative volumes remained between the 5th and 75th percentiles between the ages of 45 and 70 years. In MAPT pathogenic variant carriers, frontal lobe volume was already at the 5th percentile at age 45 years and showed a further decline between the ages 50 and 60 years. Temporal lobe volume started in the 50th percentile at age 45 years but showed fastest decline over time compared with other brain structures. Frontal, temporal, parietal, and cerebellar volume already started below the 5th percentile compared with the reference centile curves at age 45 years for C9orf72 pathogenic variant carriers, but there was minimal decline over time until the age of 60 years. DISCUSSION: We provide evidence for longitudinal brain atrophy in the presymptomatic stage of genetic FTD. The affected brain areas and the age after which atrophy rates start to accelerate and diverge from normal aging slopes differed between gene groups. These results highlight the value of normative volumetry software for disease tracking and staging biomarkers in genetic FTD. These techniques could help in identifying the optimal time window for starting treatment and monitoring treatment response.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Poos JM, Grandpierre LDM, van der Ende EL, et al. Longitudinal Brain Atrophy Rates in Presymptomatic Carriers of Genetic Frontotemporal Dementia. Neurology. 2022. PMID: 36288997. doi:10.1212/WNL.0000000000201292

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。